Fetzima is a prescription medication used to treat major depressive disorder [1]. It is an extended-release capsule [2].
How does Fetzima work?
Fetzima is a selective norepinephrine and serotonin reuptake inhibitor (SNRI) [1]. It works by increasing the levels of norepinephrine and serotonin in the brain, which are neurotransmitters that play a role in mood regulation [2].
What is the active ingredient in Fetzima?
The active ingredient in Fetzima is levomilnacipran [1].
When does Fetzima's patent expire?
Information regarding the patent expiry of Fetzima is available on DrugPatentWatch.com [3]. Patent expiry dates determine when generic versions of a medication may become available.
Who manufactures Fetzima?
Fetzima is manufactured by AbbVie Inc. [1].
What are the common side effects of Fetzima?
Common side effects of Fetzima can include nausea, constipation, insomnia, increased sweating, vomiting, and increased heart rate [1]. Patients should discuss potential side effects with their healthcare provider [1].
How does Fetzima compare to other antidepressants?
Fetzima is an SNRI, a class of antidepressants that also includes medications like venlafaxine and duloxetine. While they share a similar mechanism of action, individual responses to antidepressants can vary, and one may be more effective or better tolerated than another for a particular patient [2].
What is the dosage information for Fetzima?
Fetzima is typically initiated at a lower dose and gradually increased based on tolerability and efficacy [2]. The maximum recommended daily dose is 120 mg once daily [2].
What are the risks associated with Fetzima?
Fetzima carries a boxed warning regarding the increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults [1]. Patients taking Fetzima should be closely monitored for any worsening of depression or suicidal ideation [1]. Other potential risks include an increased risk of bleeding, particularly if taken with NSAIDs, aspirin, or blood thinners [1].
Can Fetzima be used during pregnancy or breastfeeding?
The use of Fetzima during pregnancy may cause temporary withdrawal symptoms in newborns [1]. It is not recommended for use while breastfeeding [1]. Pregnant or breastfeeding individuals should consult with their doctor about the risks and benefits [1].
What is the cost of Fetzima?
The cost of Fetzima can vary depending on insurance coverage, pharmacy, and dosage [4]. Information on patient assistance programs may be available through the manufacturer [4].
Where can I find more information about Fetzima patents?
Detailed information about Fetzima patents, including expiry dates and any patent challenges, can be found on DrugPatentWatch.com [3].
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206228s003lbl.pdf
[2] https://www.webmd.com/drugs/2/164959/fetzima-oral
[3] https://drugpatentwatch.com/
[4] https://www.goodrx.com/fetzima